Evidence map›Paper›PMID 34681092›Full record

ArticleBiology2021

Functionalization of Biotinylated Polyethylene Glycol on Live Magnetotactic Bacteria Carriers for Improved Stealth Properties.

Richa Chaturvedi, Yumin Kang, Yunji Eom, Sri Ramulu Torati, CheolGi Kim

Abstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. CD4Sensors (Basel, Switzerland) · 2026
    Pooled it
  2. Engineering Magnetotactic Bacteria as Medical Microrobots.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  3. Long-Term Tumor-Targeting Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richa ChaturvediDepartment of Emerging Materials Science, DGIST, Daegu 42988, Korea.
Yumin KangDepartment of Emerging Materials Science, DGIST, Daegu 42988, Korea.
Yunji EomDepartment of Emerging Materials Science, DGIST, Daegu 42988, Korea.
Sri Ramulu ToratiDepartment of Emerging Materials Science, DGIST, Daegu 42988, Korea.
CheolGi KimDepartment of Emerging Materials Science, DGIST, Daegu 42988, Korea.ORCID 0000-0001-9531-5758

Funding

National Research Foundation of Korea 2018R1A5A1025511
6 · The paper itself

Abstract

The early removal of drug delivery agents before reaching the affected target remains an area of interest to researchers. Several magnetotactic bacteria (MTB) have been used as self-propelled drug delivery agents, and they can also be controlled by an external magnetic field. By attaching the PEG-biotin polymer, the bacteria are turned into a stealth material that can escape from the phagocytosis process and reach the area of interest with the drug load. In the study, we developed a potential drug carrier by attaching the PEG-biotin to the MTB-through-NHS crosslinker to form a MTB/PEG-biotin complex. The attachment stability, efficacy, and bacterial viability upon attachment of the PEG-biotin polymer were investigated. Biological applications were carried out using a cytotoxicity assay of THP-1 cells, and the results indicate that the MTB/PEG-biotin complex is less harmful to cell viability compared to MTB alone. Along with cytotoxicity, an assay for cell association was also evaluated to assess the complex as a potential stealth material. The development of these complexes focuses on an easy, time-saving, and stable technique of polymer attachment with the bacteria, without damaging the cell's surface, so as to make it a strong and reliable delivery agent.

Indexed as

biotincytotoxicitydrug deliverymagnetotactic bacteriapolyethylene glycolstealth property

Identifiers

PMID34681092
PMCPMC8533374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.